From: Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis
Characteristic | Pediatric group (n = 58) (5–14y) | Adult group (n = 103) (15–60y) | p value |
---|---|---|---|
Age (year), median [IQR] | 9 [7, 11] | 31 [26, 39] | |
Sex | |||
Male | 39 (67.2%) | 56 (54.4%) | p = 0.076 |
Female | 19 (32.8%) | 47 (45.6%) | |
Asthma | 7 (12.07%) | 21 (20.39%) | p = 0.159 |
Sensitization pattern Monosensitization (Der p/Der p + Der f) Polysensitization (HDMs + †others) | 4 (6.90%)/28 (48.28%) | 9 (8.74%)/44 (42.72%) | p = 0.650 |
26 (44.82%) | 50 (48.54%) |